Vorinostat Terminated Phase 2 Trials for Stage IV Breast Cancer / Male Breast Cancer / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00132002Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer